DE69425162T2 - 4,5-diaryloxazol-derivate - Google Patents
4,5-diaryloxazol-derivateInfo
- Publication number
- DE69425162T2 DE69425162T2 DE69425162T DE69425162T DE69425162T2 DE 69425162 T2 DE69425162 T2 DE 69425162T2 DE 69425162 T DE69425162 T DE 69425162T DE 69425162 T DE69425162 T DE 69425162T DE 69425162 T2 DE69425162 T2 DE 69425162T2
- Authority
- DE
- Germany
- Prior art keywords
- aryl
- lower alkylene
- diaryloxazole
- derivatives
- suitable substituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939325962A GB9325962D0 (en) | 1993-12-20 | 1993-12-20 | Heterocyclic compounds |
GB9422404A GB9422404D0 (en) | 1994-11-07 | 1994-11-07 | Heterocyclic compounds |
PCT/JP1994/002116 WO1995017393A1 (en) | 1993-12-20 | 1994-12-16 | 4,5-diaryloxazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69425162D1 DE69425162D1 (de) | 2000-08-10 |
DE69425162T2 true DE69425162T2 (de) | 2000-12-21 |
Family
ID=26304051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69425162T Expired - Fee Related DE69425162T2 (de) | 1993-12-20 | 1994-12-16 | 4,5-diaryloxazol-derivate |
Country Status (17)
Country | Link |
---|---|
US (1) | US6025375A (de) |
EP (1) | EP0736018B1 (de) |
JP (1) | JPH09506894A (de) |
KR (1) | KR100345943B1 (de) |
CN (2) | CN1046714C (de) |
AT (1) | ATE194335T1 (de) |
AU (1) | AU686286B2 (de) |
CA (1) | CA2179399A1 (de) |
DE (1) | DE69425162T2 (de) |
DK (1) | DK0736018T3 (de) |
ES (1) | ES2147836T3 (de) |
GR (1) | GR3034542T3 (de) |
HU (1) | HUT76341A (de) |
PT (1) | PT736018E (de) |
RU (1) | RU2176640C2 (de) |
TW (1) | TW374086B (de) |
WO (1) | WO1995017393A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW401408B (en) * | 1995-07-21 | 2000-08-11 | Fujisawa Pharmaceutical Co | Heterocyclic compounds having prostaglandin I2 agonism |
AUPO713297A0 (en) * | 1997-06-02 | 1997-06-26 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compound |
GB9720270D0 (en) | 1997-09-25 | 1997-11-26 | Pharmagene Lab Limited | Medicaments for the treatment of migraine |
AUPP003297A0 (en) * | 1997-10-27 | 1997-11-20 | Fujisawa Pharmaceutical Co., Ltd. | 4,5-diaryloxazole compounds |
AUPP029197A0 (en) | 1997-11-10 | 1997-12-04 | Fujisawa Pharmaceutical Co., Ltd. | Benzocycloheptene derivatives |
AUPP109097A0 (en) | 1997-12-22 | 1998-01-22 | Fujisawa Pharmaceutical Co., Ltd. | Napthalene derivatives |
ES2311306T3 (es) | 1998-09-17 | 2009-02-01 | Bristol-Myers Squibb Company | Procedimiento para tratar la diabetes empleando un inhibidor de ap2 y combinaciones asociadas. |
US7358254B2 (en) | 2001-07-13 | 2008-04-15 | Bristol-Myers Squibb Company | Method for treating atherosclerosis employing an aP2 inhibitor and combination |
AUPP608898A0 (en) * | 1998-09-23 | 1998-10-15 | Fujisawa Pharmaceutical Co., Ltd. | New use of prostaglandin E2 antagonists |
US6437146B1 (en) | 1998-09-25 | 2002-08-20 | Fujisawa Pharmaceutical Co., Ltd. | Oxazole compounds as prostaglandin e2 agonists or antagonists |
AU2005201289B2 (en) * | 1999-02-12 | 2008-04-17 | President And Fellows Of Harvard College | Inhibiting formation of atherosclerotic lesions |
PL350917A1 (en) | 1999-03-05 | 2003-02-10 | Procter & Gamble | C16 unsaturated fp-selective prostaglandins analogs |
AU5249200A (en) * | 1999-06-21 | 2001-01-09 | Fujisawa Pharmaceutical Co., Ltd. | Remedies for skin ulcer |
US6894175B1 (en) * | 1999-08-04 | 2005-05-17 | The Procter & Gamble Company | 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use |
AUPQ253199A0 (en) * | 1999-08-30 | 1999-09-23 | Fujisawa Pharmaceutical Co., Ltd. | Non-prostanoid prostaglandin I2-agonist |
US7390824B1 (en) | 1999-09-07 | 2008-06-24 | Bristol-Myers Squibb Company | Method for treating diabetes employing an aP2 inhibitor and combination |
AU2000234451B2 (en) * | 2000-03-24 | 2005-09-29 | Asterand Uk Acquisition Limited | Use of prostanoid ep4 receptor antagonists for the treatment of headache and assays for such antagonists |
US20020146439A1 (en) * | 2000-03-31 | 2002-10-10 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins |
US20020013294A1 (en) * | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
WO2002085412A1 (fr) * | 2001-04-18 | 2002-10-31 | Fujisawa Pharmaceutical Co., Ltd. | Inhibiteurs de la fibrose des tissus |
CA2481035A1 (en) | 2002-04-08 | 2003-10-16 | Glaxo Group Limited | (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
GB0225548D0 (en) | 2002-11-01 | 2002-12-11 | Glaxo Group Ltd | Compounds |
TW200505446A (en) * | 2003-01-17 | 2005-02-16 | Fuj Isawa Pharmaceutical Co Ltd | Inhibitor of cox |
US20090016981A1 (en) | 2006-05-03 | 2009-01-15 | Allergan, Inc. | Therapeutic compounds |
US7439372B2 (en) * | 2006-05-03 | 2008-10-21 | Allergan, Inc. | Therapeutic compounds |
US8217027B2 (en) * | 2006-12-21 | 2012-07-10 | Abbott Laboratories | Sphingosine-1-phosphate receptor agonist and antagonist compounds |
US9365485B2 (en) | 2007-01-25 | 2016-06-14 | Allergan, Inc. | Substituted arylcyclopentenes as therapeutic agents |
EP2121609A1 (de) | 2007-01-25 | 2009-11-25 | Allergan, Inc. | Substituierte arylcyclopentene als therapeutika |
US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
TWI435874B (zh) | 2008-10-31 | 2014-05-01 | Toray Industries | 環己烷衍生物及其醫藥用途 |
WO2010122169A1 (en) * | 2009-04-24 | 2010-10-28 | Basf Se | 5-mercapto- [1,2, 4] triazole compounds and their agricultural and pharmaceutical uses |
AU2011276539A1 (en) * | 2010-06-28 | 2013-02-07 | President And Fellows Of Harvard College | Compounds for the inhibition of cellular proliferation |
US9000032B2 (en) | 2013-05-31 | 2015-04-07 | Allergan, Inc. | Substituted cyclopentenes as therapeutic agents |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
US4072689A (en) * | 1973-02-22 | 1978-02-07 | Gruppo Lepetit S.P.A. | Monoamino 2,4,5-trisubstituted oxazoles |
NZ236474A (en) * | 1989-12-20 | 1993-07-27 | Bristol Myers Squibb Co | 4,5-diphenyl-2-oxazole octanoic, nonanoic and decanoic acid and ester derivatives, preparation and pharmaceutical compositions thereof |
US5348969A (en) * | 1992-04-03 | 1994-09-20 | Bristol-Myers Squibb Company | Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors |
KR100383305B1 (ko) * | 1994-03-10 | 2003-11-01 | 후지사와 야꾸힝 고교 가부시키가이샤 | 프로스타글란딘i₂작용물질로서의나프탈렌유도체 |
-
1994
- 1994-12-16 CN CN94194557A patent/CN1046714C/zh not_active Expired - Fee Related
- 1994-12-16 WO PCT/JP1994/002116 patent/WO1995017393A1/en active IP Right Grant
- 1994-12-16 ES ES95902969T patent/ES2147836T3/es not_active Expired - Lifetime
- 1994-12-16 DK DK95902969T patent/DK0736018T3/da active
- 1994-12-16 DE DE69425162T patent/DE69425162T2/de not_active Expired - Fee Related
- 1994-12-16 HU HU9601685A patent/HUT76341A/hu unknown
- 1994-12-16 JP JP7517312A patent/JPH09506894A/ja not_active Ceased
- 1994-12-16 AT AT95902969T patent/ATE194335T1/de not_active IP Right Cessation
- 1994-12-16 KR KR1019960703222A patent/KR100345943B1/ko not_active IP Right Cessation
- 1994-12-16 AU AU12006/95A patent/AU686286B2/en not_active Ceased
- 1994-12-16 RU RU96115170/04A patent/RU2176640C2/ru not_active IP Right Cessation
- 1994-12-16 CA CA002179399A patent/CA2179399A1/en not_active Abandoned
- 1994-12-16 EP EP95902969A patent/EP0736018B1/de not_active Expired - Lifetime
- 1994-12-16 PT PT95902969T patent/PT736018E/pt unknown
- 1994-12-17 TW TW083111798A patent/TW374086B/zh active
-
1998
- 1998-06-05 US US09/092,027 patent/US6025375A/en not_active Expired - Fee Related
- 1998-07-25 CN CN98116704A patent/CN1090184C/zh not_active Expired - Fee Related
-
2000
- 2000-10-04 GR GR20000402232T patent/GR3034542T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HUT76341A (en) | 1997-08-28 |
US6025375A (en) | 2000-02-15 |
ATE194335T1 (de) | 2000-07-15 |
CN1229795A (zh) | 1999-09-29 |
DK0736018T3 (da) | 2000-09-18 |
GR3034542T3 (en) | 2001-01-31 |
AU1200695A (en) | 1995-07-10 |
CA2179399A1 (en) | 1995-06-29 |
RU2176640C2 (ru) | 2001-12-10 |
KR100345943B1 (ko) | 2002-11-30 |
WO1995017393A1 (en) | 1995-06-29 |
TW374086B (en) | 1999-11-11 |
CN1090184C (zh) | 2002-09-04 |
JPH09506894A (ja) | 1997-07-08 |
PT736018E (pt) | 2000-10-31 |
KR960706482A (ko) | 1996-12-09 |
CN1046714C (zh) | 1999-11-24 |
ES2147836T3 (es) | 2000-10-01 |
DE69425162D1 (de) | 2000-08-10 |
CN1138328A (zh) | 1996-12-18 |
EP0736018B1 (de) | 2000-07-05 |
HU9601685D0 (en) | 1996-08-28 |
EP0736018A1 (de) | 1996-10-09 |
AU686286B2 (en) | 1998-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69425162T2 (de) | 4,5-diaryloxazol-derivate | |
MX9800577A (es) | Derivados de 4,5-diaril oxazol. | |
ES2182852T3 (es) | Derivados de prolinamida. | |
IL108562A (en) | 7, 8-diaryl-1,2,3,4- terahydropyrazolo- £5,1-c| £1,2,4| triazine derivatives, methods for the preparation thereof and pharmaceutical compositions containing them | |
DE69428476D1 (de) | Heterocyclische Verbindungen als Bradykinin Antagonisten | |
WO1996016981A3 (en) | Peptide compounds for prevention and/or treatment of no-mediated diseases | |
ES2160156T3 (es) | Derivados de naftaleno como agonistas de la prostaglandina i2. | |
AP9801321A0 (en) | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-h-indole derivatives. | |
ES2093091T3 (es) | Derivado de glutation. | |
NO972938D0 (no) | Farmasöytiske piperazinforbindelser | |
FI895139A0 (fi) | Pyrrolidinderivat. | |
FI963645A0 (fi) | Silmänpainetta alentava aine | |
NO171639C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolpyrazolderivater | |
ATE228359T1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |